Company profile ABIO

ARCA biopharma Inc
arca was founded on the belief that a precision medicine approach to drug development, tailoring medical treatment to the individual genetic characteristics of patients, can enable more effective therapies, improve patient outcomes and reduce healthcare costs. arca’s lead development program is intended to be a direct implementation of those ideas. gencaro™ (bucindolol hydr...ochloride) is being developed as a potential treatment for atrial fibrillation (af). arca has identified genetic variations in cardiac receptors that we believe may predict individual patient response to gencaro™, giving gencaro™ the potential to be the first genetically-targeted prevention treatment for af. Show More
Quarter analysis & expected interestLast update: February 08 2024 12:43:12.

After 39 days of this quarter the interest is at 14.0. Based on that we can calculate that during remaining 52 days it will total up to 33.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
201927
50
85.2% QoQ
69
38.0% QoQ
12
-82.6% QoQ
2020 65
140.7% YoY 441.7% QoQ
157
214.0% YoY 141.5% QoQ
105
52.2% YoY -33.1% QoQ
29
141.7% YoY -72.4% QoQ
2021 60
-7.7% YoY 106.9% QoQ
24
-84.7% YoY -60.0% QoQ
74
-29.5% YoY 208.3% QoQ
101
248.3% YoY 36.5% QoQ
2022 44
-26.7% YoY -56.4% QoQ
32
33.3% YoY -27.3% QoQ
19
-74.3% YoY -40.6% QoQ
15
-85.1% YoY -21.1% QoQ
2023 34
-22.7% YoY 126.7% QoQ
45
40.6% YoY 32.4% QoQ
60
215.8% YoY 33.3% QoQ
42
180.0% YoY -30.0% QoQ
2024 14
-58.8% YoY -66.7% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and ARCA biopharma search interestLast update: February 08 2024 12:43:11.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 12:43:13.

The average 5 years interest of ARCA biopharma was 4.13 per week.
The last year interest of ARCA biopharma compared to the last 5 years has changed by -9.2%.
This is something to be checked.
The last year interest is comparable to 5 years ago. It has changed only by 7.14%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for ARCA biopharma therapies to provide analysis

Correlation between past revenue and ARCA biopharma therapies search interest

There is not enough data for ARCA biopharma therapies to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for ARCA biopharma therapies to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for ARCA biopharma cardiovascular to provide analysis

Correlation between past revenue and ARCA biopharma cardiovascular search interest

There is not enough data for ARCA biopharma cardiovascular to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for ARCA biopharma cardiovascular to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for ARCA biopharma COVID-19 to provide analysis

Correlation between past revenue and ARCA biopharma COVID-19 search interest

There is not enough data for ARCA biopharma COVID-19 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for ARCA biopharma COVID-19 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for ARCA biopharma treatment to provide analysis

Correlation between past revenue and ARCA biopharma treatment search interest

There is not enough data for ARCA biopharma treatment to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for ARCA biopharma treatment to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for ARCA biopharma research to provide analysis

Correlation between past revenue and ARCA biopharma research search interest

There is not enough data for ARCA biopharma research to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for ARCA biopharma research to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for ARCA biopharma jobs to provide analysis

Correlation between past revenue and ARCA biopharma jobs search interest

There is not enough data for ARCA biopharma jobs to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for ARCA biopharma jobs to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for ARCA biopharma reviews to provide analysis

Correlation between past revenue and ARCA biopharma reviews search interest

There is not enough data for ARCA biopharma reviews to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for ARCA biopharma reviews to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for ARCA biopharma -stock -company to provide analysis

Correlation between past revenue and ARCA biopharma -stock -company search interest

There is not enough data for ARCA biopharma -stock -company to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for ARCA biopharma -stock -company to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for ABIO
Earnings date: 2024-02-22 After close
Company name: ARCA biopharma Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2024-09-06T17:08:49-04:00

SEC
SC 13D Form - General Statement of Acquisition of Beneficial Ownership - Oruka Therapeutics, Inc. (0000907654) (Subject)

2024-09-06T17:07:49-04:00

SEC
3 Form - Initial statement of beneficial ownership of securities - Oruka Therapeutics, Inc. (0000907654) (Issuer)

2024-09-06T17:07:01-04:00

SEC
3 Form - Initial statement of beneficial ownership of securities - Oruka Therapeutics, Inc. (0000907654) (Issuer)

2024-09-06T17:06:02-04:00

SEC
3 Form - Initial statement of beneficial ownership of securities - Oruka Therapeutics, Inc. (0000907654) (Issuer)

2024-09-06T17:05:07-04:00

SEC
3 Form - Initial statement of beneficial ownership of securities - Oruka Therapeutics, Inc. (0000907654) (Issuer)

2024-09-06T17:04:12-04:00

SEC
3 Form - Initial statement of beneficial ownership of securities - Oruka Therapeutics, Inc. (0000907654) (Issuer)

2024-09-06T17:03:26-04:00

SEC
3 Form - Initial statement of beneficial ownership of securities - Oruka Therapeutics, Inc. (0000907654) (Issuer)

2024-09-06T17:02:26-04:00

SEC
3 Form - Initial statement of beneficial ownership of securities - Oruka Therapeutics, Inc. (0000907654) (Issuer)

2024-09-06T17:01:37-04:00

SEC
3 Form - Initial statement of beneficial ownership of securities - Oruka Therapeutics, Inc. (0000907654) (Issuer)

2024-09-06T17:00:20-04:00

SEC
3 Form - Initial statement of beneficial ownership of securities - Oruka Therapeutics, Inc. (0000907654) (Issuer)

2024-09-05T17:18:25-04:00

SEC
8-K Form - Current report, items 1.01, 2.01, 2.02, 3.03, 4.01, 5.01, 5.02, 5.03, 5.05, 5.06, 7.01, and 9.01 - Oruka Therapeutics, Inc. (0000907654) (Filer)

2024-08-30T17:57:33-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - ARCA biopharma, Inc. (0000907654) (Issuer)

2024-08-29T20:50:15Z

GlobeNewswire
ARCA biopharma Announces Completion of Merger with Oruka Therapeutics and Implementation of Reverse Stock Split

2024-08-26T19:53:54-04:00

SEC
425 Form - Prospectuses and communications, business combinations - ARCA biopharma, Inc. (0000907654) (Subject)

2024-08-26T19:51:15-04:00

SEC
8-K Form - Current report, items 8.01 and 9.01 - ARCA biopharma, Inc. (0000907654) (Filer)